News & Events

28/09/2018

The latest results of the project to be presented at The Lysing Meeting, New York, USA

Elżbieta Jagielska will attend The Lysing Meeting (3-8 Nov 2018) in New York, USA and present recent results on peptidoglycan...
Czytaj więcej
23/08/2018 / News

Recent Auresine project achievements have been presented at ISSSI Meeting, Denmark

Izabela Sabała attended the ISSSI meeting (Internal Symposium on Staphylococci and Staphylococcal infections) in Copenhagen, Denmark (August 23-26, 2018) and...
Czytaj więcej
09/07/2018 / News

Recent research achievement presented at EMBO Workshop, Poland

Izabela Sabała and Elżbieta Jagielska presented recent research results at EMBO Workshop „Viruses of Microbes” in Wrocław, Poland.
Czytaj więcej
11/06/2018 / News

Auresine technology to be presented at EMBO Workshop, Switzerland

Izabela Sabała has attended the ISSSI meeting (Internal Symposium on Staphylococci and Staphylococcal infections) in Ascona (June 11-15, 2018), Switzerland...
Czytaj więcej
12/03/2018 / News

Auresine team attended partnering conference Bio-Europe Spring, Amsterdam 2018

Izabela Sabała and Elżbieta Jagielska attended partnering event in Amsterdam where they met global and local companies from biotechnology, pharmacy...
Czytaj więcej
27/09/2017 / News

MINIATURA grant for Elżbieta Jagielska

Dr. Elżbieta Jagielska, Senior Scientist at the Auresine project, has received funding under the MINIATURA 1 scheme organized by the...
Czytaj więcej
11/09/2017 / News

Auresine technology at Eurobiotech Congress in Cracow, Poland

Izabela Sabała and Elżbieta Jagielska presented results of our research and Auresine technology potential at Eurobiotech Congress in Cracow, Poland....
Czytaj więcej
21/06/2017 / News

Izabela Sabała was awarded with TEAM-TECH grant

Dr Izabela Sabała was awarded with grant by Foundation for Polish Science in TEAM-TECH program for the project „INFECTLESS: New...
Czytaj więcej
07/03/2017 / News

Auresine won 3rd place in the “Closer to people” competition

Auresine project (“We sell license to kill Staphylococcus”) won 3rd place in the Life Sciences & Healthcare category in the...
Czytaj więcej
10/11/2016 / News

Auresine to present at 1st International Symposium on Antimicrobial Hydrolytic Enzymes, Rockefeller University, New York, USA

Dr Izabela Sabała presented poster: „Structural studies of M23 enzymes and their potential applications„ in which she presented results of...
Czytaj więcej
07/11/2016 / News

Izabela Sabała a finalist at Darboven Idee Grant

Dr Izabela Sabała took part in the competition for Polish business women in the best idea for innovative business and...
Czytaj więcej
27/10/2016 / News

Auresine awarded Silver Medal at iENA 2016

Izabela Sabała, Elżbieta Jagielska and Matthias Bochtler were awarded the SILVER MEDAL for “Auresine – new way to combat staphylococcus”...
Czytaj więcej
01/08/2016 / News

Results of our research were published in Microbial Drug Resistance

Elzbieta Jagielska, Olga Chojnacka, and Izabela Sabała, „LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions” Microb Drug...
Czytaj więcej
20/07/2016 / News

Dr Izabela Sabała one of two laureates of the VI edition of “Innovation is a woman” competition

Dr. Izabela Sabała, head of the Auresine project, was awarded for the biotechnological applications of bacteriolytic enzyme. As a reward,...
Czytaj więcej
26/06/2016 / News

Auresine to present at Gordon Research Conference Bacterial Cell Surfaces in Mount Snow, VT, USA

Dr Elżbieta Jagielska presented poster with results of our research on interactions of cell targeting domains with peptidoglycan network, „Peptidoglycan...
Czytaj więcej